Investor profile
Samsara Biocapital has backed 3 European tech companies across 4 funding rounds between 2021 and 2023, joining rounds totalling €281M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| EyeBiotech | UK | 2 | €118M |
| Pepgen | UK | 1 | €95M |
| Immunos Therapeutics | Switzerland | 1 | €68M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Pepgen | Other | €95M | 2021-08 |
| Immunos Therapeutics | Series B | €68M | 2022-06 |
| EyeBiotech | Series A | €61M | 2023-11 |
| EyeBiotech |
| Series A |
| €57M |
| 2022-02 |
